What is the recommended antibiotic treatment for a patient with a soft tissue skin abscess, specifically considering the use of Keflex (cephalexin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Keflex (Cephalexin) for Soft Tissue Skin Abscess

Incision and drainage is the primary treatment for skin abscesses, and antibiotics including Keflex are generally unnecessary after adequate drainage unless specific high-risk features are present. 1, 2

Primary Treatment Approach

The most important intervention for a skin abscess is incision and drainage—antibiotics alone are insufficient and should not replace surgical drainage. 1, 3

  • For simple, uncomplicated abscesses after adequate drainage, antibiotics are not recommended. 1, 2
  • Studies demonstrate that placebo achieves 90.5% cure rates after drainage of MRSA abscesses, compared to 84.1% with cephalexin, showing no significant benefit from antibiotics. 4
  • The single published trial specifically examining antibiotics for surgical site infections found no clinical benefit when drainage was adequate. 1

When Antibiotics ARE Indicated After Drainage

Antibiotics should be added to drainage in the following situations:

  • Systemic signs of infection: Temperature >38°C or <36°C, heart rate >90-110 beats/minute, respiratory rate >24 breaths/minute, or WBC >12,000 or <4,000 cells/μL. 1, 2
  • Extensive surrounding cellulitis: Erythema and induration extending >5 cm from the abscess margin. 1, 2
  • Immunocompromised patients: Including diabetes, HIV, chronic corticosteroid use, or other immunosuppressive conditions. 1, 2
  • Location-specific concerns: Abscesses near the axilla or perineum require broader coverage including anaerobes (cephalexin is inadequate). 2, 3
  • Failed drainage or inability to achieve adequate drainage. 2

Cephalexin Dosing and Selection

When antibiotics are indicated and MRSA is NOT suspected, cephalexin 500 mg orally four times daily for 5-7 days is appropriate. 2, 5, 3

  • Cephalexin provides excellent coverage for methicillin-susceptible Staphylococcus aureus (MSSA) and streptococci, the most common pathogens in simple skin abscesses. 3, 6
  • Clinical cure rates exceed 95% with cephalexin for uncomplicated soft tissue infections when appropriate pathogens are present. 6, 7
  • The WHO elevated cephalexin to first-choice status in 2021 for mild skin and soft tissue infections due to appropriate spectrum and tolerability. 3

Critical Limitation: MRSA

Cephalexin has NO activity against MRSA and should NOT be used when community-acquired MRSA is suspected or confirmed. 3, 8

When to Suspect MRSA and Avoid Cephalexin:

  • Previous MRSA infection or colonization. 2, 3
  • High local MRSA prevalence (>10-30% in your community). 3
  • Purulent drainage with surrounding cellulitis. 5
  • Recent hospitalization or healthcare exposure. 3
  • Injection drug use. 3
  • Close contact with someone with MRSA. 3

Alternative Antibiotics for MRSA Coverage:

  • Oral options: Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily, doxycycline 100 mg twice daily, or clindamycin 300-450 mg four times daily. 2, 5, 3
  • IV options (for severe infections): Vancomycin 15 mg/kg every 12 hours, daptomycin, linezolid, or ceftaroline. 2, 5, 3

Important Clinical Nuance

A landmark pediatric study found no difference between cephalexin and clindamycin for treating uncomplicated SSTIs despite 69% MRSA prevalence, with 94-97% cure rates in both arms when drainage was performed. 8 This suggests that adequate drainage with close follow-up may be more important than initial antibiotic choice for uncomplicated abscesses, even in MRSA-prevalent areas. 8

However, this does not mean cephalexin is appropriate for MRSA—rather, it emphasizes that drainage is paramount and antibiotics may be unnecessary altogether for simple abscesses. 8, 4

Duration and Monitoring

  • Treatment duration: 5-7 days for most uncomplicated cases after adequate drainage. 2, 5
  • Reassess within 48-72 hours to ensure clinical improvement. 2, 5
  • Extend treatment only if infection has not improved within this timeframe. 2
  • Obtain cultures during drainage to guide targeted therapy if patient fails to improve. 2

Common Pitfalls to Avoid

  • Never treat abscesses with antibiotics alone without drainage—this is the most common error and leads to treatment failure. 1, 3
  • Do not use cephalexin for necrotizing infections—these require urgent surgical debridement plus broad-spectrum IV antibiotics (vancomycin plus piperacillin-tazobactam or a carbapenem). 1, 5, 3
  • Do not use cephalexin for animal or human bites—these require amoxicillin-clavulanate for anaerobic coverage. 5, 3
  • Do not fail to obtain cultures before starting antibiotics—this prevents targeted therapy if empiric treatment fails. 2, 3
  • Do not assume beta-lactams are always appropriate—local MRSA epidemiology must guide empiric choices. 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment for Leg Abscess

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cephalexin for Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Selection for Soft Tissue Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ofloxacin versus cephalexin for treating skin and soft tissue infections.

International journal of dermatology, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.